ACHV

Achieve Life Sciences Inc

• Seeking Alpha·04/01 15:39

  Achieve Life Sciences: The Recent Sell Off Skews The Outcomes

• TipRanks·03/27 00:14

  Achieve Life Sciences Maps High‑Stakes Path To 2027

• Reuters·03/26 21:52

  Achieve Life Sciences publishes corporate presentation; cytisinicline PDUFA set for June 20, 2026 for nicotine dependence smoking cessation treatment

• Seeking Alpha·03/26 17:28

  Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation

• Benzinga·03/26 12:58

  Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

• Reuters·03/26 12:31

  Achieve Life Sciences announces Nicotine & Tobacco Research study; cytisinicline shows 99% α4β2 receptor binding on low nausea risk due to -8% 5-HT3 displacement

• TipRanks·03/25 19:20

  Analysts Are Bullish on Top Healthcare Stocks: KalVista Pharmaceuticals (KALV), Achieve Life Sciences (ACHV)

• Dow Jones·03/25 10:55

  Achieve Life Sciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

• Benzinga·03/25 10:45

  HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

• TipRanks·03/25 10:35

  Regulatory Fears Overdone: CMC-Driven Volatility Creates Attractive Entry Point Ahead of 2027 Cytisinicline Launch

• TipRanks·03/25 06:00

  Execution Risks Cloud Achieve Life Sciences’ Commercial Plans for Cytisinicline

• TipRanks·03/24 20:40

  Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX) and Achieve Life Sciences (ACHV)

• Seeking Alpha·03/24 19:16

  Iran is said to offer conditional passage through Strait of Hormuz amid shipping crisis

• Seeking Alpha·03/24 19:15

  Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by U.S. manufacturing shift and AI-driven commercialization

• Benzinga·03/24 17:05

  12 Health Care Stocks Moving In Tuesday's Intraday Session